ONC creates chief health information officer role

The Office of the National Coordinator for Health IT (ONC) has created a new position of chief health information officer which will be filled by Michael James McCoy, MD.

The board-certified obstetrician/gynecologist has practiced clinically for more than 20 years, and has over a decade of experience in health IT, with special interests in interoperability, user experience and person-centered care, according to an email sent to ONC staff by National Coordinator Karen DeSalvo, MD, MPH, MSc.

"In this new role, Mike will lead development of ONC clinical policy for standards and regulatory matters to help ensure ONC initiatives improve health beyond healthcare. He will also be the lead clinical subject matter expert on interoperability."

McCoy's background includes leadership roles in nearly all facets of the health IT domain, DeSalvo wrote, "from use in small physician offices to large national health delivery systems, IT development and standards development organizations."

McCoy's involvement in standards development includes Integrating the Healthcare Enterprise (IHE) Patient Care Coordination domain, and the IHE International Board of Directors. He represented the American College of Obstetricians and Gynecologists as its health IT strategist in multiple SDO forums; has worked with the Certification Commission for Health Information Technology as co-chair of the Women’s Health Work Group; and participated on the Child Health Expert Panel and the Ambulatory Work Group. 

McCoy "is passionate, as am I, on making effective use of interoperable healthcare IT while ensuring a person-centered health system that results in the best outcomes possible," wrote DeSalvo.

McCoy will begin in his new role on Jan. 26 and will report directly to DeSalvo.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.